OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer

PENNINGTON, N.J. and SAN DIEGO, April 29, 2022 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the body’s immune system to target and attack…

Click here to view original post